Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|January 4, 2013
Transfusion strategies for acute upper gastrointestinal bleedingCàndid Villanueva, Alan Colomo, Alba Bosch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2008
Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulationJuan Turnes, Juan Carlos García-Pagán, Monica González, et al.
Gastroenterology|January 18, 2016
Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With CirrhosisJuan G Abraldes, Candid Villanueva, Carles Aracil, et al.
Gastroenterologia Y Hepatologia|January 19, 2016
[Evaluation and treatment of the critically ill cirrhotic patient]Javier Fernández, Carles Aracil, Elsa Solà, et al.
Hepatology (Baltimore, Md.)|October 1, 2015
Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertensionCàndid Villanueva, Agustín Albillos, Joan Genescà, et al.
Hepatology (Baltimore, Md.)|January 19, 2017
A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosisCàndid Villanueva, Isabel Graupera, Carles Aracil, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 13, 2020
Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligationAlba Ardevol, Edilmar Alvarado-Tapias, Marta Garcia-Guix, et al.
Hepatology (Baltimore, Md.)|July 18, 2017
Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapiesAlba Ardevol, Gemma Ibañez-Sanz, Joaquim Profitos, et al.
Journal for Immunotherapy of Cancer|March 18, 2025
Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapiesJoel Veas Rodriguez, Miquel Piñol, Maria Alba Sorolla, et al.
Lancet (London, England)|March 27, 2019
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trialCàndid Villanueva, Agustín Albillos, Joan Genescà, et al.
Pageof 4